Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Macaluso

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
The Primary Care Companion for CNS Disorders|October 14, 2016
Student Evaluation of the Yellow Ribbon Suicide Prevention Program in Midwest SchoolsAlexandra Flynn, Rosalee Zackula, Nicole M Klaus, et al.
Psychiatry Research|April 2, 2018
Malignant Self-Regard in clinical outpatient samplesSteven K Huprich, Matthew Macaluso, Lyle Baade, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|December 8, 2023
What Can You Learn About Psychiatry Programs from Their Website? A Content Evaluation for Potential ApplicantsAustin G Armstrong, Kenneth W Fraser, Shelby N Nix, et al.
Journal of Psychiatric Practice|September 23, 2010
The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a reviewAhsan Y Khan, Matthew Macaluso, Robert J McHale, et al.
Journal of Psychiatric Practice|March 19, 2015
Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agentSheldon Preskorn, Matthew Macaluso, D O Vishaal Mehra, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 30, 2021
Challenges of Assessing Resident Competency in Well-Being: Development of the Psychiatry Milestones 2.0 Well-Being SubcompetencyL Joy Houston, Sandra M DeJong, Adam M Brenner, et al.
The Journal of Clinical Psychiatry|June 16, 2021
Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial DatasetNadia Iovieno, George I Papakostas, Anna Feeney, et al.
Journal of Personality Assessment|March 26, 2019
Convergent and Discriminant Validity and Utility of the DSM-5 Levels of Personality Functioning Questionnaire (DLOPFQ): Associations with Medical Health Care Provider Ratings and Measures of Physical HealthSharon M Nelson, Steven K Huprich, Kevin B Meehan, et al.
Psychiatry Research|April 5, 2023
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal sprayIbrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
The Primary Care Companion for CNS Disorders|October 14, 2016
Student Evaluation of the Yellow Ribbon Suicide Prevention Program in Midwest SchoolsAlexandra Flynn, Rosalee Zackula, Nicole M Klaus, et al.
Psychiatry Research|April 2, 2018
Malignant Self-Regard in clinical outpatient samplesSteven K Huprich, Matthew Macaluso, Lyle Baade, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|December 8, 2023
What Can You Learn About Psychiatry Programs from Their Website? A Content Evaluation for Potential ApplicantsAustin G Armstrong, Kenneth W Fraser, Shelby N Nix, et al.
Journal of Psychiatric Practice|September 23, 2010
The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a reviewAhsan Y Khan, Matthew Macaluso, Robert J McHale, et al.
Journal of Psychiatric Practice|March 19, 2015
Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agentSheldon Preskorn, Matthew Macaluso, D O Vishaal Mehra, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 30, 2021
Challenges of Assessing Resident Competency in Well-Being: Development of the Psychiatry Milestones 2.0 Well-Being SubcompetencyL Joy Houston, Sandra M DeJong, Adam M Brenner, et al.
The Journal of Clinical Psychiatry|June 16, 2021
Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial DatasetNadia Iovieno, George I Papakostas, Anna Feeney, et al.
Journal of Personality Assessment|March 26, 2019
Convergent and Discriminant Validity and Utility of the DSM-5 Levels of Personality Functioning Questionnaire (DLOPFQ): Associations with Medical Health Care Provider Ratings and Measures of Physical HealthSharon M Nelson, Steven K Huprich, Kevin B Meehan, et al.
Psychiatry Research|April 5, 2023
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal sprayIbrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, et al.
Pageof 7